tubulin polymerization assay kit (Cytoskeleton Inc)
Structured Review

Tubulin Polymerization Assay Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 714 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tubulin+polymerization+assay+kit/Tubulin+polymerization+assay+using+%3E99%25+pure+tubulin%2C+OD+based+-+Porcine/pmc13620138-544-7-12
Average 96 stars, based on 714 article reviews
Images
1) Product Images from "CPT1A-mediated IDO1 succinylation shapes EGFRvIII-driven resistance to tumor electric field therapy in glioblastoma"
Article Title: CPT1A-mediated IDO1 succinylation shapes EGFRvIII-driven resistance to tumor electric field therapy in glioblastoma
Journal: Nature Communications
doi: 10.1038/s41467-026-77927-w
Figure Legend Snippet: A Western blot analysis of AhR in cytoplasmic and nuclear fractions of TBD0220 and LN229-EGFRvIII cells. TEFT treatment promotes AhR nuclear translocation, B Immunofluorescence staining of AhR (red) and DAPI (blue). TEFT induces AhR nuclear accumulation, which is reversed by IDO1 knockdown or osimertinib. Scale bars, 10 μm, C ATAC-seq footprinting showing increased chromatin accessibility at the AhR binding motif in EGFRvIII cells versus wild-type, D GO enrichment analysis of AhR target genes (identified by intersecting ATAC-seq and ChIP-Atlas), highlighting “Mitotic Cell Cycle” and “Microtubule Cytoskeleton” as top pathways, E Representative immunofluorescence images of mitotic spindles (α-tubulin, green) and chromosomes (DAPI, blue) in LN229 cells. TEFT causes severe spindle disruption and multipolar mitosis in wild-type cells, whereas EGFRvIII cells maintain bipolar spindles. This protection is lost upon IDO1 knockdown or osimertinib treatment, F Quantification of cells with abnormal nuclei following TEFT treatment ( n = 3 biological replicates per group), G Venn diagram intersecting RNA-seq (upregulated), ATAC-seq (accessible peaks), and ChIP-Atlas (AhR binding targets) data, identifying DCLK1 as a key downstream target, H Western blot confirming the upregulation of DCLK1 protein in EGFRvIII cells upon TEFT, I Immunofluorescence images of mitotic spindles in DCLK1 -knockdown cells. Silencing DCLK1 sensitizes EGFRvIII cells to TEFT-induced spindle defects, J Quantification of abnormal nuclear morphology in DCLK1-depleted cells ( n = 3 biological replicates per group), K Venn diagram integrating multi-omics data with microtubule/GTPase-related genes, identifying ARHGEF2 (GEF-H1) as another target, L In vitro tubulin polymerization assay in TBD0220 cells under the indicated conditions. IDO1 knockdown, ARHGEF2 knockdown, osimertinib, or epacadostat reduced the microtubule-polymerizing activity associated with EGFRvIII-mediated TEFT resistance. Data are presented as mean ± SD. The exact n values and definitions of biological replicates are specified for the relevant panels. Statistical tests were as follows: two-tailed unpaired Student’s t test for panel J ; ordinary one-way ANOVA followed by two-sided Šídák-adjusted multiple-comparisons tests for panel F . Exact P values, adjusted for multiple comparisons where applicable, are shown in the corresponding panels. Source data are provided as a Source Data file.
Techniques Used: Western Blot, Analysis, Translocation Assay, Immunofluorescence, Staining, Knockdown, Footprinting, Binding Assay, Disruption, RNA Sequencing, Morphology, Biomarker Discovery, In Vitro, Polymerization Assay, Activity Assay, Two Tailed Test
Related Articles
Polymerization Assay:Article Title: Discovery of quinoxaline-chalcone derivatives as covalent colchicine binding site inhibitors for breast and fibrosarcoma treatment. Article Snippet: Targeting the colchicine binding site is an attractive pharmacological strategy to overcome the multidrug resistance microtubule-targeting agents are faced with.. Herein, a series of novel covalent quinoxaline-chalcone derivatives were rationally designed using pharmacophore fusion with S-IV-25 as lead compound.. All obtained target compounds were evaluated for their inhibitory activities and the structure-activity relationships were summarized, leading to the identification of a potent colchicine binding site inhibitor 10v. Article Title: Biological activity and toxicological safety of Dittrichia viscosa: Mechanistic insights into antigenotoxicity, antiproliferative activity, and drug synergy Article Snippet: Dittrichia viscosa, a traditionally used medicinal plant, was comprehensively evaluated for its biological activities and toxicological safety.. Phytochemical profiling revealed chlorogenic acid and rutin as the major phenolic components in its methanolic and aqueous extracts.. Safety assessments, including the Ames test, showed no mutagenic effects and demonstrated protective activity against known mutagens. Article Title: Multifaceted anticancer mechanisms of tribenzyltin carboxylates: DNA minor groove targeting and inhibition of key enzymes in DNA replication, nucleotide synthesis, and redox homeostasis. Article Snippet: Tribenzyltin carboxylates complexes, namely tri(4-fluorobenzyl)tin[(N,N-diisopropylcarbamothioyl)sulfanyl]acetate (C1) and tribenzyltin isonicotinate (C9), have been reported to exhibit significant anticancer activity via the death receptor and mitochondrial apoptotic pathway.. However, understanding their upstream mechanism remains crucial.. This study utilized both in silico and in vitro approaches to elucidate their mechanism of action. Article Title: Discovery of a Novel Coumarin/Thiazole Chalcone Hybrid as a Potent Dual Inhibitor of Tubulin and Carbonic Anhydrases IX & XII with Promising Anti-Proliferative Activity. Article Snippet: .. Tubulin Polymerization Inhibition The effect of compound 6 on microtubule assembly was evaluated using a Article Title: Discovery and biological evaluation of 3-aryl-5-(3,4,5-trimethoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine derivatives as novel tubulin inhibitors with potent anticancer efficacy in vitro and in vivo. Article Snippet: As the structural foundation of microtubules, tubulin represents a pivotal molecular target in anticancer drug discovery.. The design and evaluation of small-molecule tubulin polymerization inhibitors continues to be a productive strategy for identifying next-generation chemotherapeutic agents.. Based on systematic structural analysis of known tubulin inhibitors targeting the colchicine-binding site and available computational tubulinligand models, a focused library of 3-aryl-5-(3,4,5-trimethoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine derivatives was rationally designed and synthesized as candidate tubulin polymerization inhibitors. Article Title: CPT1A-mediated IDO1 succinylation shapes EGFRvIII-driven resistance to tumor electric field therapy in glioblastoma Article Snippet: .. Tubulin polymerization kinetics were monitored using the Article Title: A Dual-Mechanism Targeted Cross-Convergence Prodrug Activation Strategy Enabled by Biological Stimulus Amplification toward Precision Cancer Therapy Article Snippet: .. The effect of compounds W436 and colchicine on the polymerization of tubulin was determined by using a Article Title: In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models Article Snippet: .. The LDH Cytotoxicity Detection Kit was obtained from Roche Diagnostics, Mannheim, Germany, the TMRE Mitochondrial Membrane Potential Assay Kit from Abcam, Cambridge, UK, and the Inhibition:Article Title: Discovery of a Novel Coumarin/Thiazole Chalcone Hybrid as a Potent Dual Inhibitor of Tubulin and Carbonic Anhydrases IX & XII with Promising Anti-Proliferative Activity. Article Snippet: .. Tubulin Polymerization Inhibition The effect of compound 6 on microtubule assembly was evaluated using a In Vitro:Article Title: Discovery and biological evaluation of 3-aryl-5-(3,4,5-trimethoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine derivatives as novel tubulin inhibitors with potent anticancer efficacy in vitro and in vivo. Article Snippet: As the structural foundation of microtubules, tubulin represents a pivotal molecular target in anticancer drug discovery.. The design and evaluation of small-molecule tubulin polymerization inhibitors continues to be a productive strategy for identifying next-generation chemotherapeutic agents.. Based on systematic structural analysis of known tubulin inhibitors targeting the colchicine-binding site and available computational tubulinligand models, a focused library of 3-aryl-5-(3,4,5-trimethoxyphenyl)-5H-pyrrolo[2,3-b]pyrazine derivatives was rationally designed and synthesized as candidate tubulin polymerization inhibitors. Membrane:Article Title: In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models Article Snippet: .. The LDH Cytotoxicity Detection Kit was obtained from Roche Diagnostics, Mannheim, Germany, the TMRE Mitochondrial Membrane Potential Assay Kit from Abcam, Cambridge, UK, and the |
